Align Technology | ALGN - Selling And Administration Expenses

Stock Price
190.02
Daily Change
0.62 0.33%
Monthly
11.81%
Yearly
-0.22%
Q1 Forecast
184.13

Align Technology reported $441.68M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
3M USD 965M 145M Dec/2025
Align Technology USD 441.68M 23.88M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Bruker USD 247.2M 4.7M Dec/2025
Cardinal Health USD 1.5B 43M Dec/2025
Charles River Laboratories USD 196.14M 18.55M Dec/2025
Cooper Companies USD 419.2M 12M Sep/2025
Danaher USD 2.03B 35M Dec/2025
Dentsply International USD 355M 21M Sep/2025
Dexcom USD 299.9M 31.5M Dec/2025
Henry Schein USD 760M 17M Sep/2025
Idexx Laboratories USD 275.68M 10.58M Dec/2025
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 169.05M 10.84M Sep/2025
IQVIA Holdings USD 468M 46M Dec/2025
Masimo USD 116.4M 20.5M Sep/2025
McKesson USD 2.03B 44M Dec/2025
Mettler Toledo International USD 259.83M 11.43M Dec/2025
Revvity USD 251.73M 9.82M Dec/2025
Solventum Corp USD 744M 28M Sep/2025
Stryker USD 2.14B 150M Dec/2025
Teleflex USD 281.76M 66.68M Sep/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Veeva Systems USD 128.19M 9.41M Sep/2025
Waters USD 240.01M 25.78M Dec/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025
Zoetis USD 619M 40M Dec/2025